日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ZFP148 is a transcriptional repressor of cytolytic effector CD8(+) T cell differentiation

ZFP148是细胞溶解效应CD8(+) T细胞分化的转录抑制因子

Xiao, Tong; Chen, Xingyu; Song, No-Joon; Brown, Ryan J; Ma, Anjun; Mandula, Jay K; Yousif, Amir; Wang, Yi; Le, Minh Quynh May; Li, Jianying; Gao, Fengxia; Weaver, Bella; Chen, Heng-Yi; Lay, Fang-Yun; Sundi, Debasish; Velegraki, Maria; Weltge, Payton; Merchant, Juanita L; Rubinstein, Mark P; Oestreich, Kenneth J; Lio, Chan-Wang Jerry; Ghoneim, Hazem E; Li, Xue; Theodorescu, Dan; Xin, Gang; Ma, Qin; Cui, Weiguo; Li, Zihai

Using ctDNA to Inform Adjuvant Therapy for Urologic Malignancies

利用ctDNA指导泌尿系统恶性肿瘤的辅助治疗

Goradia, Rajvi; Goodstein, Taylor; Sundi, Debasish; Sood, Akshay; Dason, Shawn; Singer, Eric A

BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy

BRD4抑制可导致MDSC凋亡并增强免疫检查点阻断疗法的效果。

Savardekar, Himanshu; Stiff, Andrew; Liu, Alvin; Wesolowski, Robert; Schwarz, Emily; Garbarine, Ian C; Duggan, Megan C; Zelinskas, Sara; Li, Jianying; Lapurga, Gabriella; Abreo, Alexander; Savardekar, Lohith; Parker, Ryan; Sabella, Julia; DiVincenzo, Mallory J; Benner, Brooke; Sun, Steven H; Quiroga, Dionisia; Scarberry, Luke; Xin, Gang; Dey, Anup; Ozato, Keiko; Yu, Lianbo; Hasanov, Merve; Sundi, Debasish; Wu, Richard C; Kendra, Kari L; Carson, William E 3rd

T cell subsets of urine-derived lymphocytes (UDLs) serve as an indicator of TILs and reflect immunological sex differences in bladder cancer.

尿液来源淋巴细胞 (UDL) 的 T 细胞亚群可作为 TIL 的指标,并反映膀胱癌的免疫性别差异。

Schafer Johanna M, Song No-Joon, Xiao Tong, Gauntner Timothy D, Jung Kyeong Joo, Fitts Emily G, Kumar Krishan, Jeon Hyeong Seon, Elaoud Ryan A, Reynolds Kelsi, Caruso Vincent M, Levin Trevor G, McConkey David, Lee Cheryl T, Pohar Kamal S, Clinton Steven K, Carson William, Chung Dongjun, Li Zihai, Sundi Debasish

Sex differences in bladder cancer: understanding biological and clinical implications

膀胱癌的性别差异:理解其生物学和临床意义

Chaudhary, Prakash; Singha, Biplab; Abdel-Hafiz, Hany A; Velegraki, Maria; Sundi, Debasish; Satturwar, Swati; Parwani, Anil V; Grivennikov, Sergei I; You, Sungyong; Goodridge, Helen S; Ma, Qin; Chang, Yuzhou; Ma, Anjun; Zheng, Bin; Theodorescu, Dan; Li, Zihai; Li, Xue

54 ESTIMATING THE INCIDENCE RATE OF POST-DIAGNOSIS BRAIN METASTASES

54 估算诊断后脑转移的发生率

Sundi, Debasish; Cohen, Jason E; Cole, Alexander P; Neuman, Brian P; Cooper, John; Faisal, Farzana A; Ross, Ashley E; Schaeffer, Edward M; Zuo, H; Liu, T; Han, Y; Mou, L; Yuan, Y

Roles of Androgen Receptor Signaling in Urothelial Carcinoma

雄激素受体信号传导在尿路上皮癌中的作用

Sundi, Debasish; Collier, Katharine A; Yang, Yuanquan; Diaz, Dayssy Alexandra; Pohar, Kamal S; Singer, Eric A; Gupta, Sanjay; Carson, William E 3rd; Clinton, Steven K; Li, Zihai; Messing, Edward M

Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer

黑色素瘤抗原家族A(MAGE A)作为膀胱癌的潜在生物标志物和治疗靶点

Verma, Shiv; Swain, Diya; Kushwaha, Prem Prakash; Brahmbhatt, Smit; Gupta, Karishma; Sundi, Debasish; Gupta, Sanjay

Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies

新辅助免疫疗法在泌尿生殖系统恶性肿瘤中的作用

Khorasanchi, Adam; Jatwani, Karan; Meng, Lingbin; Collier, Katharine A; Sundi, Debasish; Dason, Shawn; Singer, Eric A; Gopalakrishnan, Dharmesh; Mortazavi, Amir; Chatta, Gurkamal; Yang, Yuanquan

Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer

确保非肌层浸润性膀胱癌膀胱保留临床试验中生物标志物研究的成功

McConkey, David J; Baumann, Brian C; Cooper Greenberg, Stephanie; DeGraff, David J; Delacroix, Scott E; Efstathiou, Jason A; Foster, Jared; Groshen, Susan; Kadel, Edward E; Khani, Francesca; Kim, William Y; Lerner, Seth P; Levin, Trevor; Liao, Joseph C; Milowsky, Matthew I; Meeks, Joshua J; Miyamoto, David T; Mouw, Kent W; Pietzak, Eugene J; Solit, David B; Sundi, Debasish; Tawab-Amiri, Abdul; West, Pamela J; Wobker, Sara E; Wyatt, Alexander W; Apolo, Andrea B; Black, Peter C